Adams R - Search Results

1

The cellular ratio of immune tolerance (immunoCRIT) is a definite marker for aggressiveness of solid tumors and may explain tumor dissemination patterns.

Türbachova I, Schwachula T, Vasconcelos I, Mustea A, Baldinger T, Jones KA, Bujard H, Olek A, Olek K, Gellhaus K, Braicu I, Könsgen D, Fryer C, Ravot E, Hellwag A, Westerfeld N, Gruss OJ, Meissner M, Hasan MT, Weber M, Hoffmüller U, Zimmermann S, Loddenkemper C, Mahner S, Babel N, Berns E, Adams R, Zeilinger R, Baron U, Vergote I, Maughan T, Marme F, Dickhaus T, Sehouli J, Olek S. Türbachova I, et al. Among authors: adams r. Epigenetics. 2013 Nov;8(11):1226-35. doi: 10.4161/epi.26334. Epub 2013 Sep 26. Epigenetics. 2013. PMID: 24071829 Free article.

2

Predicting response to epidermal growth factor receptor-targeted therapy in colorectal cancer.

Adams R, Maughan T. Adams R, et al. Expert Rev Anticancer Ther. 2007 Apr;7(4):503-18. doi: 10.1586/14737140.7.4.503. Expert Rev Anticancer Ther. 2007. PMID: 17428171 Review.

3

Cetuximab therapy in first-line metastatic colorectal cancer and intermittent palliative chemotherapy: review of the COIN trial.

Adams R, Meade A, Wasan H, Griffiths G, Maughan T. Adams R, et al. Expert Rev Anticancer Ther. 2008 Aug;8(8):1237-45. doi: 10.1586/14737140.8.8.1237. Expert Rev Anticancer Ther. 2008. PMID: 18699762 Review.

4

Derived neutrophil lymphocyte ratio is predictive of survival from intermittent therapy in advanced colorectal cancer: a post hoc analysis of the MRC COIN study.

Grenader T, Nash S, Adams R, Kaplan R, Fisher D, Maughan T, Bridgewater J. Grenader T, et al. Among authors: adams r. Br J Cancer. 2016 Mar 15;114(6):612-5. doi: 10.1038/bjc.2016.23. Epub 2016 Feb 18. Br J Cancer. 2016. PMID: 26889974 Free PMC article. Clinical Trial.

5

Derived neutrophil to lymphocyte ratio as a prognostic factor in patients with advanced colorectal cancer according to RAS and BRAF status: a post-hoc analysis of the MRC COIN study.

Wood G, Grenader T, Nash S, Adams R, Kaplan R, Fisher D, Maughan T, Bridgewater J. Wood G, et al. Among authors: adams r. Anticancer Drugs. 2017 Jun;28(5):546-550. doi: 10.1097/CAD.0000000000000488. Anticancer Drugs. 2017. PMID: 28252533 Free PMC article. Clinical Trial.

6

Prospective patient stratification into robust cancer-cell intrinsic subtypes from colorectal cancer biopsies.

Alderdice M, Richman SD, Gollins S, Stewart JP, Hurt C, Adams R, McCorry AM, Roddy AC, Vimalachandran D, Isella C, Medico E, Maughan T, McArt DG, Lawler M, Dunne PD. Alderdice M, et al. Among authors: adams r. J Pathol. 2018 May;245(1):19-28. doi: 10.1002/path.5051. Epub 2018 Mar 25. J Pathol. 2018. PMID: 29412457 Free PMC article.

7

Toxicity associated with combination oxaliplatin plus fluoropyrimidine with or without cetuximab in the MRC COIN trial experience.

Adams RA, Meade AM, Madi A, Fisher D, Kay E, Kenny S, Kaplan RS, Maughan TS. Adams RA, et al. Br J Cancer. 2009 Jan 27;100(2):251-8. doi: 10.1038/sj.bjc.6604877. Br J Cancer. 2009. PMID: 19165196 Free PMC article. Clinical Trial.

8

Chemotherapy-free intervals for patients with metastatic colorectal cancer remain an option.

Maughan T, Adams R, Wilson R, Seymour M, Meade A, Kaplan R. Maughan T, et al. Among authors: adams r. J Clin Oncol. 2010 Jun 10;28(17):e275-6; author reply e277-8. doi: 10.1200/JCO.2009.27.8218. Epub 2010 May 3. J Clin Oncol. 2010. PMID: 20439628 No abstract available.

9

Molecular subtype-specific efficacy of anti-EGFR therapy in colorectal cancer is dependent on the chemotherapy backbone.

Ten Hoorn S, Sommeijer DW, Elliott F, Fisher D, de Back TR, Trinh A, Koens L, Maughan T, Seligmann J, Seymour MT, Quirke P, Adams R, Richman SD, Punt CJA, Vermeulen L. Ten Hoorn S, et al. Among authors: adams r. Br J Cancer. 2021 Oct;125(8):1080-1088. doi: 10.1038/s41416-021-01477-9. Epub 2021 Jul 12. Br J Cancer. 2021. PMID: 34253874 Free PMC article.

10

Oxaliplatin/capecitabine vs oxaliplatin/infusional 5-FU in advanced colorectal cancer: the MRC COIN trial.

Madi A, Fisher D, Wilson RH, Adams RA, Meade AM, Kenny SL, Nichols LL, Seymour MT, Wasan H, Kaplan R, Maughan TS; COIN trial research group. Madi A, et al. Among authors: adams ra. Br J Cancer. 2012 Sep 25;107(7):1037-43. doi: 10.1038/bjc.2012.384. Epub 2012 Aug 30. Br J Cancer. 2012. PMID: 22935584 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,411 results

Search Page

Filters